NuCana
NCNA
#11102
Rank
S$5.37 M
Marketcap
S$1.29
Share price
-2.88%
Change (1 day)
-74.79%
Change (1 year)

Earnings for NuCana (NCNA)

Earnings in 2026 (TTM): -S$25.14 Million

According to NuCana 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$36.08 Million, an increase over its 2024 earnings that were of -S$37.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NuCana from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$25.14 Million-30.33%
2025 -S$36.08 Million-4.23%
2024 -S$37.67 Million-24.16%
2023 -S$49.67 Million-27.12%
2022 -S$68.15 Million-13.88%
2021 -S$79.14 Million45.6%
2020 -S$54.36 Million29.44%
2019 -S$41.99 Million12.74%
2018 -S$37.25 Million-8.89%
2017 -S$40.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion 700.08%๐Ÿ‡บ๐Ÿ‡ธ USA